Patents by Inventor Lawrence Flora

Lawrence Flora has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of osteoporosis
    Patent number: 4822609
    Abstract: A method for treating or preventing osteoporosis is disclosed. Bone cells are synchronized during a bone cell activating period; bone resorption, which normally follows activation, is inhibited using a polyphosphonate; bone formation is allowed to occur in the rest period during which nutrient supplements may be administered to the patient. The method shortens the natural cycle time of bone formation/resorption, resulting in a faster bone build-up.
    Type: Grant
    Filed: September 12, 1986
    Date of Patent: April 18, 1989
    Assignee: The Procter & Gamble Company
    Inventor: Lawrence Flora
  • Treatment of osteoporosis
    Patent number: 4812304
    Abstract: A method for treating or preventing osteoporosis is disclosed. Bone cells are synchronized during a bone cell activating period; bone resorption, which normally follows activation, is inhibited using a polyphosphonate; bone formation is allowed to occur in the rest period during which nutrient supplements may be administered to the patient.
    Type: Grant
    Filed: September 12, 1986
    Date of Patent: March 14, 1989
    Assignee: The Procter & Gamble Company
    Inventors: Colin Anderson, Lawrence Flora
  • Regimen for treating osteoporosis
    Patent number: 4761406
    Abstract: A method for treating or preventing osteoporosis utilizing a cyclic regimen comprising alternating for two or more cycles the administration of a bone resorption inhibiting polyphosphonate and a no treatment (rest) period. Further disclosed is a kit for use in implementing this method of treatment.
    Type: Grant
    Filed: June 6, 1985
    Date of Patent: August 2, 1988
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Benjamin F. Floyd
  • Phenylacetate anti-inflammatory composition
    Patent number: 4282214
    Abstract: The anti-inflammatory activity of fenoprofen, ketoprofen, MK-830 and other phenylacetic acid-based anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl.sub.2 MDP.
    Type: Grant
    Filed: October 22, 1979
    Date of Patent: August 4, 1981
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Marion D. Francis
  • Salicylate anti-inflammatory composition
    Patent number: 4275059
    Abstract: The anti-inflammatory activity of aspirin and other salicylate-based, anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl.sub.2 MDP.
    Type: Grant
    Filed: July 31, 1978
    Date of Patent: June 23, 1981
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Marion D. Francis
  • Indole anti-inflammatory composition
    Patent number: 4269828
    Abstract: The anti-inflammatory activity of indomethacin, indoxole, and other indole-based drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl.sub.2 MDP.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: May 26, 1981
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Marion D. Francis
  • Isobutylphenylacetate anti-inflammatory composition
    Patent number: 4264582
    Abstract: The anti-inflammatory activity of ibuprofen, ibufenac and other p-(isobutylphenyl)acetic acid-based anti-inflammatory drugs is enhanced by adminstration thereof in conjuction with a phosphonate compound such as EHDP or Cl.sub.2 MDP.
    Type: Grant
    Filed: October 22, 1979
    Date of Patent: April 28, 1981
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Marion D. Francis
  • Pyrazolidine anti-inflammatory composition and methods of use
    Patent number: 4216212
    Abstract: The anti-inflammatory activity of phenylbutazone, oxyphenbutazone, and other pyrazolidine-based anti-inflammatory drugs is enhanced by administration thereof in conjunction with a phosphonate compound such as EHDP or Cl.sub.2 MDP.
    Type: Grant
    Filed: June 8, 1978
    Date of Patent: August 5, 1980
    Assignee: The Procter & Gamble Company
    Inventors: Lawrence Flora, Marion D. Francis